BioCentury This Week

BioCentury This Week

BioCentury 397 - Ep. 387 - Psychedelics at FDA, Mike Davis’ CDER & tRNAs

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.

For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.

00:00
00:00

Episoder

397-

Ep. 387 - Psychedelics at FDA, Mike Davis’ CDER & tRNAs

14 sep. 2026
396-

Ep. 386 - Novartis misses, pharma deals analysis, MFN carve-outs

08 sep. 2026
395-

Ep. 385 - MFN deals, Lilly takeout, FDA pick Overton

31 aug. 2026
394-

Ep. 384 - Back to School Special: The global FIH trials race

27 aug. 2026
393-

Ep. 383 - Moderna, Genentech obesity deal, Trump's FDA pick

24 aug. 2026